Merck KGaA’s planned $17 billion acquisition of Sigma-Aldrich is set to be completed on November 18 following final approval of the blockbuster deal by the European Commission, the life sciences tools and technologies giant said today.
The EC approval followed its determination that Honeywell was a suitable buyer of Sigma-Aldrich’s laboratory research chemicals business. The divestment was directed by the EC in June as a condition for its approval of Sigma-Aldrich’s acquisition by Merck, first announced in September 2014.
Last month, Honeywell said it would acquire parts of Sigma-Aldrich’s solvents and inorganics operationsfor about €105 million. Honeywell said the deal would build on its existing portfolio of Burdick & Jackson® high-purity solvents and reagents.
Honeywell’s announcement came almost a month after Sigma-Aldrich said it expected the Merck acquisition to close by the end of November.
Full content: The Wall Street Transcript
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI